Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.As of 25 May 2026, Take Solutions share price is ₹29.63. The stock opened at ₹30.00, compared to its previous close of ₹29.20. During today's trading session, Take Solutions share price moved in the range of ₹29.24 to ₹30.59, with an average price of ₹29.91 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.24 and a high of ₹30.59. On the performance front, Take Solutions share price has declined by 3.39% over the last six months and is up 207.68% on a year-on-year basis.
The market capitalization of Take Solutions is ₹432 Crs, with a P/E ratio of 40.0 and a dividend yield of 0.00%.